Penicillin g
As of the edition of 20 October 2026, Penicillin g is a small molecule: marketed, first approved in 1960 (ES).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2010
- Kind
- Small molecule
- Brand name
- Bicillin L-A
- First approved
- 1 March 1960 (ES)
- Approvals on record
- 20 in 6 regions
- Holder of the most recent approval
- Leman SKL SA; 11 holders in all
- Registered trials
- 26, 3 stopped early
- Disease areas
- Infections; Urinary and reproductive; Lungs and airways; Bones, joints and muscles; Ear, nose and throat; Heart and blood vessels
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 9 | 6 | 1 | 0 |
| Phase 1 | 3 | 2 | 0 | 1 |
| Phase 2 | 2 | 1 | 0 | 0 |
| Phase 3 | 5 | 2 | 1 | 2 |
| Phase 4 | 7 | 1 | 4 | 0 |
| All trials | 26 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Baxter Healthcare | Later holder | 1990 to now |
| Grünenthal | Applicant | 2003 to now |
| Casper Pharma | Acquired holder | 2018 to now |
| Pfizer | Applicant, Later holder, Earlier holder and Lead sponsor of trials | 2018 to now |
| Meiji Seika Pharma | Applicant |